Kratzsch Carsten, Peters Frank T, Kraemer Thomas, Weber Armin A, Maurer Hans H
Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Saarland, D-66421 Homburg (Saar), Germany.
J Mass Spectrom. 2003 Mar;38(3):283-95. doi: 10.1002/jms.440.
A liquid chromatographic/mass spectrometric assay with atmospheric pressure chemical ionization (APCI-LC/MS) is presented for the fast and reliable screening and identification and for the precise and sensitive quantification of 15 neuroleptic (antipsychotic) drugs and three of their relevant metabolites in plasma. It allows confirmation of the diagnosis of a neuroleptic overdose and monitoring of psychiatric patients' compliance. The neuroleptics amisulpride, bromperidol, clozapine, droperidol, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perazine, pimozide, risperidone, sulpiride, zotepine and zuclopenthixol and the pharmacologically active metabolites norclozapine, clozapine N-oxide and 9-hydroxyrisperidone were extracted from plasma using solid-phase extraction and were separated on a Merck LiChroCART column with Superspher 60 RP Select B as the stationary phase. Gradient elution was performed using aqueous ammonium formate and acetonitrile. After screening and identification in the scan mode using the authors' new LC/MS library, the neuroleptics were quantified in the selected-ion mode. The quantification assay was fully validated. It was found to be selective and proved to be linear from sub-therapeutic to over therapeutic concentrations for all analytes. The corresponding reference levels are listed. The accuracy and precision data were within the required limits. The analytes were stable in frozen plasma for at least 1 month. The method was successfully applied to several authentic plasma samples from patients treated or intoxicated with various neuroleptics. The validated LC/MS assay has proved to be appropriate for the isolation, separation, screening, identification and quantification of various neuroleptics in plasma for clinical toxicology and therapeutic drug monitoring purposes.
本文介绍了一种采用大气压化学电离的液相色谱/质谱分析法(APCI-LC/MS),用于快速、可靠地筛查和鉴定以及精确、灵敏地定量血浆中的15种抗精神病药物及其3种相关代谢物。该方法可用于确认抗精神病药物过量的诊断,并监测精神病患者的用药依从性。抗精神病药物氨磺必利、溴哌利多、氯氮平、氟哌利多、三氟噻吨、氟奋乃静、氟哌啶醇、美哌隆、奥氮平、奋乃静、匹莫齐特、利培酮、舒必利、佐替平、珠氯噻醇以及药理活性代谢物去甲氯氮平、氯氮平N-氧化物和9-羟基利培酮,通过固相萃取从血浆中提取,并在以Superspher 60 RP Select B为固定相的默克LiChroCART柱上进行分离。使用甲酸铵水溶液和乙腈进行梯度洗脱。在使用作者新的LC/MS库以扫描模式进行筛查和鉴定后,以选择离子模式对抗精神病药物进行定量。定量分析方法得到了充分验证。结果表明该方法具有选择性,并且所有分析物在低于治疗浓度至高于治疗浓度范围内均呈线性。列出了相应的参考水平。准确度和精密度数据在规定范围内。分析物在冷冻血浆中至少稳定1个月。该方法已成功应用于来自接受各种抗精神病药物治疗或中毒患者的多个真实血浆样本。经过验证的LC/MS分析方法已证明适用于临床毒理学和治疗药物监测目的的血浆中各种抗精神病药物的分离、筛选、鉴定和定量。